Bellerophon Therapeutics CEO Fabian Tenenbaum's 2019 pay falls 40% to $1.4M
Bellerophon Therapeutics reports 2019 executive compensation
By ExecPay News
Published: April 23, 2020
Bellerophon Therapeutics reported fiscal year 2019 executive compensation information on April 23, 2020.
In 2019, three executives at Bellerophon Therapeutics received on average a compensation package of $807K, a 33% decrease compared to previous year.
Average pay of disclosed executives at Bellerophon Therapeutics
Fabian Tenenbaum, Chief Executive Officer, received $1.4M in total, which decreased by 40% compared to 2018. 42% of Tenenbaum's compensation, or $586K, was in option awards. Tenenbaum also received $372K in bonus, $425K in salary, as well as $17K in other compensation.
Peter Fernandes, Chief Regulatory and Safety Officer, received a compensation package of $534K, which decreased by 23% compared to previous year. 61% of the compensation package, or $324K, was in salary.
Assaf Korner, Chief Financial Officer, earned $488K in 2019, a 20% decrease compared to previous year.
Related executives
You may also like
Source: SEC filing on April 23, 2020.